Philippe Halfon, M.D., Ph.D., Pharm.D., founder acting as President CEO
Dr. Halfon is presently CEO of Alphabio Laboratory (Marseille, France, 10 ME of revenues) in charge of R&D.
is specialized in molecular virology.
Dr. Halfon is a worldwide virological expert for HIV and HBV and acts as a peer-reviewer for virological scientific reviews.
published more than 100 international publication.
acted previously as a consultant for Roche Diagnostics, France (1997-2000), and for Schering Plough, France (1998-2005).
Dr Halfon is the Chief Scientific Officer and CEO of Genoscience until a CSO is recruited.
is responsible for the scientific validation of the technology through completing retrospective studies and submitting results to major scientific reviews over Q4 2001 and Q1 2002, and participating in international conferences.
is also co-author of the VIRADAPT study, which validated the effectiveness of treatment using resistance testing (genotyping).
was nominated as one of the 30 best managers in France with Alphabio Laboratory.